TickerFacts.

Propanc Biopharma, Inc. (PPCB): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2019-06-30, while the company's latest annual report covers the year ended 2026-06-30. Its later filings do not report this line under the concept TickerFacts maps.

$28.1K
Year ended 2019-06-30
$30.5K2017-06-30: $29.0K2018-06-30: $30.5K2019-06-30: $28.1K$28.1K
2017-06-30 Cost of Revenue (USD) 2019-06-30
Period endedCost of RevenueChange YoYSource filing
2019-06-30$28.1K-8.1%2019-10-15, From 2018-07-01
2018-06-30$30.5K+5.3%2019-10-15, From 2017-07-01
2017-06-30$29.0Kn/a2018-09-17, From 2016-07-01